Filed: 8/14/2026ACC: 0001104659-26-097182
📋 What this filing means
REDMILE GROUP, LLC filed this quarterly 13F‑HR report disclosing 39 equity positions with a total reported market value of $1.49B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
39
Positions
$1.49B
Total AUM (reported)
105.72M
Total Shares
Allocation by class
COM$1.33B89.4%
SPONSORED ADS$42.22M2.8%
COM NEW$40.68M2.7%
ADS$23.77M1.6%
SHS$19.99M1.3%
COM CL A$17.22M1.2%
COMMON STOCK$7.95M0.5%
Portfolio Concentration
Top 3$601.12M40.4%
4–10$493.38M33.1%
11–25$315.64M21.2%
Rest$79.38M5.3%
Top 3 weight
40.4%
Top 10 weight
73.5%
Voting Authority Distribution
Total shares with voting rights: 105.72M
Sole
Full voting authority
105.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole39
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings39
Rows:
SCHOLAR ROCK HLDG CORP
SOLEShares4.31M
TypeSH
Market value$237.11M
15.92%
Sole
4.31M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares632K
TypeSH
Market value$234.90M
15.77%
Sole
632K
Shared
0.00
None
0.00
STOKE THERAPEUTICS INC
SOLEShares3.95M
TypeSH
Market value$129.11M
8.67%
Sole
3.95M
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares4.91M
TypeSH
Market value$104.08M
6.99%
Sole
4.91M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares4.07M
TypeSH
Market value$98.83M
6.64%
Sole
4.07M
Shared
0.00
None
0.00
ABSCI CORPORATION
SOLEShares6.74M
TypeSH
Market value$78.11M
5.24%
Sole
6.74M
Shared
0.00
None
0.00
ANNEXON INC
SOLEShares11.87M
TypeSH
Market value$67.78M
4.55%
Sole
11.87M
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares4.37M
TypeSH
Market value$52.34M
3.51%
Sole
4.37M
Shared
0.00
None
0.00
SHATTUCK LABS INC
SOLEShares6.89M
TypeSH
Market value$47.83M
3.21%
Sole
6.89M
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.41M
TypeSH
Market value$44.41M
2.98%
Sole
1.41M
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
SOLEShares1.16M
TypeSH
Market value$39.96M
2.68%
Sole
1.16M
Shared
0.00
None
0.00
AGOMAB THERAPEUTICS NV
SOLEShares2.73M
TypeSH
Market value$35.49M
2.38%
Sole
2.73M
Shared
0.00
None
0.00
FATE THERAPEUTICS INC
SOLEShares12.87M
TypeSH
Market value$34.76M
2.33%
Sole
12.87M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares640.20K
TypeSH
Market value$23.86M
1.60%
Sole
640.20K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares2.16M
TypeSH
Market value$23.77M
1.60%
Sole
2.16M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares503.32K
TypeSH
Market value$19.48M
1.31%
Sole
503.32K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares1.95M
TypeSH
Market value$19.47M
1.31%
Sole
1.95M
Shared
0.00
None
0.00
NUVATION BIO INC
SOLEShares3.03M
TypeSH
Market value$17.22M
1.16%
Sole
3.03M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares433.92K
TypeSH
Market value$16.15M
1.08%
Sole
433.92K
Shared
0.00
None
0.00
CLIMB BIO INC
SOLEShares1.23M
TypeSH
Market value$15.99M
1.07%
Sole
1.23M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares7.39M
TypeSH
Market value$15.30M
1.03%
Sole
7.39M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares265.17K
TypeSH
Market value$15.17M
1.02%
Sole
265.17K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares229.37K
TypeSH
Market value$13.85M
0.93%
Sole
229.37K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares491.65K
TypeSH
Market value$12.85M
0.86%
Sole
491.65K
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares11.53M
TypeSH
Market value$12.33M
0.83%
Sole
11.53M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SCHOLAR ROCK HLDG CORPSOLE | COM | 4.31M | SH | $237.11M 15.92% | 4.31M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 632K | SH | $234.90M 15.77% | 632K | 0.00 | 0.00 |
STOKE THERAPEUTICS INCSOLE | COM | 3.95M | SH | $129.11M 8.67% | 3.95M | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 4.91M | SH | $104.08M 6.99% | 4.91M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 4.07M | SH | $98.83M 6.64% | 4.07M | 0.00 | 0.00 |
ABSCI CORPORATIONSOLE | COM | 6.74M | SH | $78.11M 5.24% | 6.74M | 0.00 | 0.00 |
ANNEXON INCSOLE | COM | 11.87M | SH | $67.78M 4.55% | 11.87M | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 4.37M | SH | $52.34M 3.51% | 4.37M | 0.00 | 0.00 |
SHATTUCK LABS INCSOLE | COM | 6.89M | SH | $47.83M 3.21% | 6.89M | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.41M | SH | $44.41M 2.98% | 1.41M | 0.00 | 0.00 |
BEAM THERAPEUTICS INCSOLE | COM | 1.16M | SH | $39.96M 2.68% | 1.16M | 0.00 | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | SPONSORED ADS | 2.73M | SH | $35.49M 2.38% | 2.73M | 0.00 | 0.00 |
FATE THERAPEUTICS INCSOLE | COM | 12.87M | SH | $34.76M 2.33% | 12.87M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 640.20K | SH | $23.86M 1.60% | 640.20K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 2.16M | SH | $23.77M 1.60% | 2.16M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 503.32K | SH | $19.48M 1.31% | 503.32K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 1.95M | SH | $19.47M 1.31% | 1.95M | 0.00 | 0.00 |
NUVATION BIO INCSOLE | COM CL A | 3.03M | SH | $17.22M 1.16% | 3.03M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 433.92K | SH | $16.15M 1.08% | 433.92K | 0.00 | 0.00 |
CLIMB BIO INCSOLE | COM | 1.23M | SH | $15.99M 1.07% | 1.23M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 7.39M | SH | $15.30M 1.03% | 7.39M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 265.17K | SH | $15.17M 1.02% | 265.17K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 229.37K | SH | $13.85M 0.93% | 229.37K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 491.65K | SH | $12.85M 0.86% | 491.65K | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | SHS | 11.53M | SH | $12.33M 0.83% | 11.53M | 0.00 | 0.00 |
Page 1 of 2